Overview
Maki Hirata practices practicing medicine in Tokushima, Japan.
Hirata is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Mosaicism, Shingles, X-Linked Severe Combined Immunodeficiency, and Spermatogenesis Arrest.
They are actively involved in clinical research, co-authoring 74 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maki Hirata
Is Maki Hirata a top-rated expert for Mosaicism?
MediFind is an objective health platform that identifies experts based on real-world data. Maki Hirata is classified as an Advanced expert for Mosaicism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maki Hirata participate in research or clinical trials?
Yes. Maki Hirata has published 74 articles and abstracts on conditions like Mosaicism. You can view a list of Maki Hirata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MosaicismHirata isAdvanced. Learn about Mosaicism.
- ShinglesHirata isAdvanced. Learn about Shingles.
- Experienced
- Severe Combined Immunodeficiency (SCID)
- Spermatogenesis ArrestHirata isExperienced. Learn about Spermatogenesis Arrest.
- X-Linked Severe Combined Immunodeficiency